LLY vs BDX
By Alex · Tickerpine
Eli Lilly and Company vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BDX |
|---|---|---|
| Price | $1,208.12 | $155.92 |
| Market cap | $1.08T | $42.96B |
| P/E ratio | 42.9 | 27.3 |
| ROE | 107.46% | 6.67% |
| Profit margin | 34.99% | 5.12% |
| Revenue growth | 55.50% | 5.20% |
| Dividend yield | 0.57% | 2.69% |
| Beta | 0.52 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BDX in plain English
- LLY is the bigger company — about 25.1× the market cap of BDX.
- BDX is cheaper on earnings (P/E 27.3 vs 42.9).
- LLY earns a higher return on equity (107% vs 7%).
- LLY is growing revenue faster (56% vs 5%).
- BDX has the higher dividend yield (2.69% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.